Abstract:The Cancer Proteome Atlas (TCPA) project collects reverse-phase protein arrays (RPPA)-based proteome datasets from nearly 8000 samples across 32 cancer types. This study aims to investigate the pan-cancer proteome signature and identify cancer subtypes of glioma, kidney cancer, and lung cancer based on TCPA data. We first visualized the tumor clustering models using t-distributed stochastic neighbour embedding (t-SNE) and biclustering heatmap. Then, three feature selection methods (pyHSICLasso, XGBoost, and Random Forest) were performed to select protein features for classifying cancer subtypes in training dataset, and the LibSVM algorithm was empolyed to test classification accuracy in the validation dataset. Clustering analysis revealed that different kinds of tumors have relatively distinct proteomic profiling based on tissue or origin. We identified 20, 10, and 20 protein features with the highest accuracies in classifying subtypes of glioma, kidney cancer, and lung cancer, respectively. The predictive abilities of the selected proteins were confirmed by receiving operating characteristic (ROC) analysis. Finally, the Bayesian network was utilized to explore the protein biomarkers that have direct causal relationships with cancer subtypes. Overall, we highlight the theoretical and technical applications of machine learning based feature selection approaches in the analysis of high-throughput biological data, particularly for cancer biomarker research. Significance: Functional proteomics is a powerful approach for characterizing cell signaling pathways and understanding their phenotypic effects on cancer development. The TCPA database provides a platform to explore and analyze TCGA pan-cancer RPPA-based protein expression. With the advent of the RPPA technology, the availability of high-throughput data in TCPA platform has made it possible to use machine learning methods to identify protein biomarkers and further differentiate subtypes of cancer based on proteomic data. In this study, we highlight the role of feature selection and Bayesian network in discovery protein biomarker for classifying cancer subtypes based on functional proteomic data. The application of machine learning methods in the analysis of high-throughput biological data, particularly for cancer biomarker researches, which have potential clinical values in developing individualized treatment strategies.

Feature Selection and Assessment of Lung Cancer Sub-types by Applying Predictive Models

Identification of Key Genes and Evaluation of Clinical Outcomes in Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis

Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis

Heterogeneous Gene Expression Cross-Evaluation of Robust Biomarkers Using Machine Learning Techniques Applied to Lung Cancer

Using feature selection and Bayesian network identify cancer subtypes based on proteomic data

An integrated bioinformatics approach to early diagnosis, prognosis and therapeutics of non-small-cell lung cancer

Analysis of Gene Expression Profiles of Lung Cancer Subtypes with Machine Learning Algorithms.

An Integrated Data Analysis Using Bioinformatics and Random Forest to Predict Prognosis of Patients With Squamous Cell Lung Cancer

Predicting the Lung Adenocarcinoma and Its Biomarkers by Integrating Gene Expression and DNA Methylation Data.

A feature selection-based framework to identify biomarkers for cancer diagnosis: A focus on lung adenocarcinoma

A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies

Multiomics-Based Feature Extraction and Selection for the Prediction of Lung Cancer Survival

Identification of Effective Diagnostic Genes and Immune Cell Infiltration Characteristics in Small Cell Lung Cancer by Integrating Bioinformatics Analysis and Machine Learning Algorithms

Machine learning and bioinformatics analysis of diagnostic biomarkers associated with the occurrence and development of lung adenocarcinoma

Lung adenocarcinoma and lung squamous cell carcinoma cancer classification, biomarker identification, and gene expression analysis using overlapping feature selection methods

Integrated machine learning to predict the prognosis of lung adenocarcinoma patients based on SARS‐COV‐2 and lung adenocarcinoma crosstalk genes

Subclassification of lung adenocarcinoma through comprehensive multi-omics data to benefit survival outcomes

Single-cell RNA-seq Analysis to Identify Potential Biomarkers for Diagnosis, and Prognosis of Non-Small Cell Lung Cancer by Using Comprehensive Bioinformatics Approaches.

Radiomics-Based Features for Prediction of Histological Subtypes in Central Lung Cancer

Identidication of novel biomarkers in non-small cell lung cancer using machine learning

Evaluation of A Lung Cancer Rna Expression Subtyping Panel and Comparison with Histologic Diagnosis in Lung Tumor Samples from Multiple Data Sets Including the Cancer Genome Atlas (Tcga).